Antitumorigenic targets of cannabinoids – current status and implications.

Author(s): Ramer R, Hinz B

Institute of Toxicology and Pharmacology , Rostock University Medical Center , Rostock , Germany

Subject: Cancer View the study

Abstract:

The main goal of targeting endocannabinoid structures for systemic anticancer treatment is the comparatively good safety profile of cannabinoid compounds. In addition, antitumorigenic mechanisms of cannabinoids are not restricted to a single molecular cascade but involve multiple effects on various levels of cancer progression such as angiogenesis and metastasis...

Source: Expert Opinion on Therapeutic Targets (Price: $89)
Share Tweet

More medical studies related to Cancer:

View all medical studies >>

Subscribe for daily cannabis news, announcements, and business insights.

Рекламная полиграфическая продукция читать далее
surrogacycmc.com

узнать больше